MedPath
TGA Approval

VYNDAMAX tafamidis 61 mg soft gelatin capsule blister pack (314813)

314813

VYNDAMAX tafamidis 61 mg soft gelatin capsule blister pack

Pfizer Australia Pty Ltd

March 16, 2020

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/44e92413a9f5f858a5493ee80cb9bacc.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/df392a6f3671b808fb2512faa0b52274.pdf

Active Ingredients

tafamidis

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VYNDAMAX tafamidis 61 mg soft gelatin capsule blister pack (314813) - TGA 批准文号 | MedPath